Former healthcare CEO starts private equity firm

Amy Baxter | | Health Exec | Management

The former CEO of health insurance provider Anthem, Joseph Swedish, has started a private equity firm as a co-founder, Axios reported.

Swedish stepped down as CEO of Anthem in 2017 after four years in the position. The role was taken over by Gail Boudreaux, who was formerly the CEO of UnitedHealthcare.

The emergence of the firm, Concord Health Partners, underscores the growing influx of private equity funding into the healthcare space. The firm invests in expansion-stage companies with value-add opportunities in the healthcare industry.

See the full story below:

Joseph Swedish starts private equity firm

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Veterans Affairs denies it discriminates based on politics, marital status
Ivenix infusion kits recalled by FDA due to serious manufacturing defect
FDA recalls pediatric breathing kits after eight serious injuries
Dental marketing firm Gargle likely source of 8M leaked patient records
FDA recalls Zyno infusion pumps, citing risk of death
Q&A: The role of employers in achieving healthcare price transparency

Around the web

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Cardiovascular Business
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.